相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis
Daniel Caldeira et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2019)
Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age
Aaqib H. Malik et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis
In-Soo Kim et al.
JOURNAL OF CARDIOLOGY (2018)
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants The Stockholm Experience
Tomas Forslund et al.
STROKE (2018)
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
Ying Bai et al.
AGE AND AGEING (2018)
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
Giulia Renda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
George Ntaios et al.
STROKE (2017)
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Peter Bronnum Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Peter Bronnum Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
Deirdre A. Lane et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis
Corey S. Miller et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Eri Toda Kato et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Risk of Bleeding With Dabigatran in Atrial Fibrillation
Inmaculada Hernandez et al.
JAMA INTERNAL MEDICINE (2015)
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L. Halperin et al.
CIRCULATION (2014)
Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age - Insight From J-ROCKET AF
Masatsugu Hori et al.
CIRCULATION JOURNAL (2014)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
Flemming Skjoth et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control
Ye Wang et al.
THROMBOSIS RESEARCH (2014)
Cardiovascular disease in Europe: epidemiological update
Melanie Nichols et al.
EUROPEAN HEART JOURNAL (2013)
Atrial fibrillation prevalence revisited
L. Friberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation
William L. Baker et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
John W. Eikelboom et al.
CIRCULATION (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Outlier and influence diagnostics for meta-analysis
Wolfgang Viechtbauer et al.
RESEARCH SYNTHESIS METHODS (2010)
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Daniel E. Singer et al.
ANNALS OF INTERNAL MEDICINE (2009)
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials
S. J. Edwards et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions
F. Song et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
Elaine M. Hylek et al.
CIRCULATION (2007)
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
J Heeringa et al.
EUROPEAN HEART JOURNAL (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses
F Song et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
